Gynaecomastia after spironolactone and potassium canrenoate.
Bellati
G
G
Idéo
G
G
D001201:Ascites / Q000188:drug therapy; D002191:Canrenoic Acid / Q000009:adverse effects*; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D008297:Male; D011245:Pregnadienes / Q000009:adverse effects*; D011446:Prospective Studies; D013148:Spironolactone / Q000009:adverse effects*
D011245:Pregnadienes; D013148:Spironolactone; D002191:Canrenoic Acid